RIGEL PHARMACEUTICALS, INC. Public Float
RIGEL PHARMACEUTICALS, INC. (RIGL) had Public Float of $331.60 million as of 2025-06-30, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-03
- 2025-06-30: Entity Public Float $331.60M.
- 2024-06-30: Entity Public Float $143.10M.
- 2023-06-30: Entity Public Float $222.70M.
- 2022-06-30: Entity Public Float $193.70M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $331.60M 10-K · filed 2026-03-03 |
| 2024-06-30 | $143.10M 10-K · filed 2025-03-04 |
| 2023-06-30 | $222.70M 10-K · filed 2024-03-05 |
| 2022-06-30 | $193.70M 10-K · filed 2023-03-07 |
| 2021-06-30 | $740.00M 10-K · filed 2022-03-01 |
| 2020-06-30 | $308.57M 10-K · filed 2021-03-02 |
| 2019-06-30 | $437.42M 10-K · filed 2020-02-27 |
| 2018-06-30 | $470.77M 10-K · filed 2019-02-28 |
| 2017-06-30 | $337.81M 10-K · filed 2018-03-06 |
| 2016-06-30 | $210.66M 10-K · filed 2017-03-07 |
| 2015-06-30 | $283.03M 10-K · filed 2016-03-08 |
| 2014-06-30 | $317.39M 10-K · filed 2015-03-03 |
| 2013-06-28 | $290.85M 10-K · filed 2014-03-04 |
| 2012-06-29 | $662.42M 10-K · filed 2013-03-05 |
| 2011-06-30 | $649.68M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |